Skip to content

Drug interactions

Enzalutamide + Macimorelin

Severity: Moderate

Enzalutamide and Macimorelin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Strong CYP3A4 inducers can reduce macimorelin exposure and lower the growth hormone response, possibly causing a false positive diagnosis of growth hormone deficiency. This affects test interpretation rather than ongoing therapy.

What this interaction means in plain words

Enzalutamide and Macimorelin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Enzalutamide belongs to Endocrine; Macimorelin belongs to Endocrine.

Evidence level: Low

Why it happens

Enzalutamide induces CYP3A4, decreasing macimorelin plasma levels and its stimulated GH release.

What to do

Where possible stop enzalutamide with adequate washout before macimorelin testing, or interpret results cautiously. Use an alternative stimulation test if enzalutamide cannot be paused.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Enzalutamide and Macimorelin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Enzalutamide with Macimorelin?

MediHelp rates the interaction as moderate. Enzalutamide and Macimorelin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Strong CYP3A4 inducers can reduce macimorelin exposure and lower the growth hormone response, possibly causing a false positive diagnosis of growth hormone deficiency. This affects test interpretation rather than ongoing therapy.

How serious is the interaction between Enzalutamide and Macimorelin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Where possible stop enzalutamide with adequate washout before macimorelin testing, or interpret results cautiously. Use an alternative stimulation test if enzalutamide cannot be paused.

What other medicines interact with Enzalutamide?

MediHelp also lists interactions of Enzalutamide with, for example, Doravirine, Elbasvir / grazoprevir, Ensitrelvir. The full list is on the Enzalutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in